Fibromyalgia Syndrome Clinical Trial
Official title:
Evaluation of Chronotype and Central Sensitization in Patients With Fibromyalgia Syndrome, Cross-sectional Study
The aim of study is to examine the chronotype preferences of patients with fibromyalgia syndrome and the relationship between central sensitization and chronotype, and to examine its relationship with pain intensity, disability and quality of life.
Fibromyalgia Syndrome (FMS); It is a syndrome characterized by chronic pain occurring in more than one part of the body and accompanied by fatigue, sleep disturbance, impairment in quality of life and daily functionality. Although FMS is seen in different age groups, it is most common in middle-aged women. FMS is classified as central sensitization syndrome, in which there is an abnormal response to painful stimuli and the processing of nociceptive stimuli in the central nervous system. In patients with FMS, pain may cause sleep disturbances such as non-restorative sleep or difficulty initiating or maintaining sleep. It is estimated that 65-99% of patients with FMS experience sleep disorders. Circadian rhythms reflect 24-hour physiological and behavioral cycles within each individual. Based on individual differences in the timing of these innate rhythms, individuals can be divided into 3 phenotypes (i.e., chronotypes): morning type (M-highest level of alertness in the morning), evening type (E most active in the evening), and intermediate type (I-neither M nor E). Chronotype is explained by both genetic and environmental factors and can be considered a fairly robust trait throughout adulthood. A study assessing 1548 people with FMS with an online survey including questions about sleep quality, well-being, pain, chronotype and FMS impact shows that late chronotypes are more affected by fibromyalgia. In another study conducted in 2019, patients with FMS were grouped according to chronotype preferences and showed that there was a strong relationship between FMS severity and poor quality of life in evening individuals. The aim of study is to examine the chronotype preferences of patients with fibromyalgia syndrome and the relationship between central sensitization and chronotype, and to examine its relationship with pain intensity, disability and quality of life. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05933486 -
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
|
Phase 4 | |
Completed |
NCT01642810 -
Online Acceptance-based Behavioural Treatment for Fibromyalgia
|
Phase 3 | |
Completed |
NCT00757679 -
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
|
Phase 2 | |
Completed |
NCT00757731 -
FMS European Long-Term Study
|
Phase 3 | |
Completed |
NCT01968772 -
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT00401830 -
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
|
Phase 2 | |
Completed |
NCT04517929 -
Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT06285045 -
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
|
N/A | |
Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 | |
Completed |
NCT02800720 -
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome
|
N/A | |
Not yet recruiting |
NCT01465477 -
Influenza Vaccination in Fibromyalgia Patients
|
N/A | |
Completed |
NCT00528710 -
Efficacy of S-Adenosylmethionine in Fibromyalgia
|
Phase 2 | |
Completed |
NCT00447083 -
Benefits of Tanning in Fibromyalgia Patients
|
N/A | |
Not yet recruiting |
NCT06147882 -
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
Completed |
NCT00464737 -
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
|
Phase 2 | |
Completed |
NCT04426864 -
Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.
|
N/A | |
Completed |
NCT02881411 -
Self Soft Tissue Therapy for Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT01389336 -
Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone
|
N/A | |
Not yet recruiting |
NCT01147263 -
Palpitations and Tachycardia in Fibromyalgia Syndrome
|
N/A |